The Royal Institute of British Architects has presented its 2009 White Rose Gold Award to a new medical centre funded by SMBCE.
The new Queen’s Centre for Oncology and Haematology at Castle Hill Hospital in Hull, also received three further RIBA awards, namely, the National Award for Architecture, the White Rose High Commendation for Landscaping, and the White Rose Best Client Award.
RIBA was founded in 1834 and its awards are considered the most prestigious design awards a building can receive in the United Kingdom. The institute’s mission is to advance architecture by demonstrating benefit to society and promoting excellence in the profession.
The centre is part of the larger Hull Hospital and constitutes a hub of excellence for the treatment of patients with cancer and blood disorders.
It features five wards, containing 116 in-patient beds, out-patient care, a drop-in centre providing psychological and emotional support, a chemotherapy day hospital, six radiotherapy treatment rooms, as well as pathology, pharmacy and medical physics facilities.
The environment has been designed by a team of architects, patients and staff to promote well-being and recovery, and provide a clean and safe hospital for patients and their families.
The centre offers stunning views of the rolling Hull landscape, which patients can enjoy through ample, bright communal rooms fitted with floor-to-ceiling windows.
It takes as its design reference from the typical villages found in the East Riding of Yorkshire, which enables it to blend into its surroundings. While the entrance has been designed to echo a village hall in appearance and scale, wards and outpatient areas are similar in form to residential cottages.
The courtyards were designed for the benefit of patients and provide the type of tranquil, natural environment that has been proven to help physical and psychological recovery.
The centre serves a wide catchment area of 1.2 million people, from Scarborough in the north to Lincoln in the south.
SMBCE staff recently visited the site to recognise the final completion of construction and the official opening.
The centre was built for a total construction cost of £44.5m, opened to patients in August 2008 and was officially inaugurated by the Queen Elizabeth II in March 2009.
The partners of the Hull Oncology and Haematology Centre project were the Hull and East Yorkshire NHS Trust and an ABN AMRO PPP Investments-led consortium, including ABN AMRO, Shepherd Construction, HLM Architects, and Operon.
The facility is a 19,902 square metre oncology and haematology unit and is located adjacent to the existing Castle Hill Hospital in Hull. It is 100% new build.
RIBA awards are given for buildings that have high architectural standards and make a substantial contribution to the local environment. The awards are annual, and have been running continuously since 1966.